All terms in ONE
Label | Id | Description |
---|---|---|
requirements section | IAO_0000641 | [A part of a document about a resource described in the document, e.g. software, that describes the requirements necessary to use the resource, e.g. operating systems, hardware, etc. in the case of a software resource.] |
purification | OBI_0001505 | [A planned process to separate a material entity into different compositions of which one or more have are purified fractions that contain higher concentration of a desired component, while others contain impurities and are not of interest] |
material component separation | OBI_0600014 | [a material processing in which components of an input material become segregated in space] |
specimen with pre- or post-mortem status | OBI_0001506 | [A specimen that has been established to be taken from a live (pre-mortem) or dead (post-mortem) organism.] |
specimen | OBI_0100051 | [A material entity that has the specimen role.] |
in vivo assay measuring T cell epitope specific treatment of disease | OBI_0001507 | [An efficacy of T cell epitope intervention experiment that detects a decrease in disease.] |
biological activity assay measuring T cell epitope specific in vivo activity | OBI_0001484 | [A T cell epitope dependent biological activity determination assay that uses an in vivo intervention experiment.] |
sampling time measurement datum | OBI_0001508 | [A time measurement datum when an observation is made or a sample is taken from a material as measured from some reference point.] |
time measurement datum | IAO_0000416 | [A scalar measurement datum that is the result of measuring a temporal interval] |
Edman degradation assay measuring MHC ligand processing and presentation | OBI_0001509 | [A MHC ligand processing and presentation assay that uses Edman degradation to identify the eluted ligands] |
mass spectrometry assay measuring MHC ligand processing and presentation of MHC ligands eluted from secreted MHC | OBI_0001510 | [A mass spectrometry of MHC ligands that identifies eluted ligands from secreted MHC.] |
mass spectrometry assay measuring MHC ligand processing and presentation | OBI_0001478 | [A MHC ligand processing and presentation assay that uses a mass spectrometry assay to identify eluted ligands] |
mass spectrometry assay | OBI_0000470 | [An assay that identifies the amount and type of material entities present in a sample by fragmenting the sample and measuring the mass-to-charge ratio of the resulting particles.] |
nasal cavity | UBERON_0001707 | [An anatomical cavity that is part of the olfactory apparatus. This includes the space bounded anteriorly by the nares and posteriorly by the choanae, when these structures are present.] |
Thing | Thing | |
disposition to be a product of antigen processing and presentation | OBI_0001511 | [A disposition of a material entity to be presented by MHC molecules on the cell surface as a result of antigen processing by an antigen presenting cell. ] |
disposition | BFO_0000016 | |
cytometric bead array assay measuring epitope specific interleukin-17A production by T cells | OBI_0001512 | [A T cell epitope specific interleukin-17A production assay that uses a cytometric bead array assay.] |
biological activity assay measuring epitope specific interleukin-17A production by T cells | OBI_0001773 | [An assay of epitope specific interleukin-17 production by T cells that detects interleukin-17A production.] |
purified MHC competitive binding assay of a MHC:ligand complex using radioactivity detection | OBI_0001513 | [A purified MHC binding assay that uses radioactivity detection to detect loss of binding of a known reference ligand due to competition by the ligand under investigation.] |